Majority of pharmaceutical plants located in disaster-prone areas, study shows
Regulatory NewsJoanne S. Eglovitch
EnvironmentalPharmaceuticalsRegulatory strategyShortagesSterile drugsSupply Chain ManagementUnited StatesUS Food and Drug Administration (FDA)